Treatment of Hepatoblastoma with Drug-eluting Bead Transarterial Chemoembolization in a 13-Month-Old Infant: A Case Report and Review of the Literature

Matthew Hoyer, Rakesh Goli, Katherine K. Barnett, Eric H. Raabe, Kelvin Hong

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Background:Prior reports have shown the utility of conventional lipiodol-based transarterial chemoembolization in hepatoblastoma. The authors describe the first reported case of hepatoblastoma treated with drug-eluting bead transarterial chemoembolization (DEB-TACE).Observations:An 11-month-old infant presented with hepatoblastoma measuring 14.3 cm. A trial of cisplatin chemotherapy followed by sequential DEB-TACE to the tumor's feeding vasculature reduced the mass to 5.3 cm. The patient tolerated both sessions of DEB-TACE without any major complication. Having demonstrated adequate disease control, the patient then underwent successful liver transplantation.Conclusion:This report provides promising evidence for the treatment of hepatoblastoma with DEB-TACE.

Original languageEnglish (US)
Pages (from-to)E123-E126
JournalJournal of Pediatric Hematology/Oncology
Volume43
Issue number1
DOIs
StatePublished - Jan 2021

Keywords

  • DEB-TACE
  • hepatoblastoma
  • interventional oncology
  • interventional radiology

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Pediatrics, Perinatology, and Child Health

Fingerprint

Dive into the research topics of 'Treatment of Hepatoblastoma with Drug-eluting Bead Transarterial Chemoembolization in a 13-Month-Old Infant: A Case Report and Review of the Literature'. Together they form a unique fingerprint.

Cite this